Metraipolis › archive › dc_749376cff57e
Rituximab in pediatric refractory nephrotic syndrome: a systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles — Europe PMC PMID:41204962
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41204962
- DOI
- 10.1007/s00467-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T17:23:17.665Z
- SHA-256 of the archived text
14625c58f425938295f9da675b541b7cc7fe3b6f6b640750aa4d173a5a2dc67b- Stable URL of this page
https://metraipolis.com/documento/dc_749376cff57e
How to cite
Rituximab in pediatric refractory nephrotic syndrome: a systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles — Europe PMC PMID:41204962 — Europe PMC (en), https://europepmc.org/article/MED/41204962 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_749376cff57e (Metraipolis archive dc_749376cff57e, sha256 14625c58f425938295f9da675b541b7cc7fe3b6f6b640750aa4d173a5a2dc67b)
BibTeX
@misc{dc749376cff57e,
title = {Rituximab in pediatric refractory nephrotic syndrome: a systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles — Europe PMC PMID:41204962},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41204962},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_749376cff57e; sha256 14625c58f425938295f9da675b541b7cc7fe3b6f6b640750aa4d173a5a2dc67b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41204962. Agents can read the archived copy with the MCP tool read_document.